πŸ‡ΊπŸ‡Έ FDA
Patent

US 7495014

Gyrase inhibitors and uses thereof

granted A61PA61P11/00A61P13/02

Quick answer

US patent 7495014 (Gyrase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P11/00, A61P13/02, A61P13/08, A61P17/00